Role of ornithine decarboxylase in breast cancer

Acta Biochimica et Biophysica Sinica

Volumn 40, Issue 3, 2008, Pages 235-243

  Deng, Wensheng ^a   Jiang, Xian ^b   Mei, Yu ^a   Sun, Jingzhong ^a   Ma, Rong ^a   Liu, Xianxi ^c   Sun, Hui ^c   Tian, Hui ^a   Sun, Xueying ^b,d  

^a SHANDONG UNIVERSITY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

^c SHANDONG UNIVERSITY   (China)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Adenovirus; Antisense; Breast cancer; Migration; Ornithine decarboxylase; Polyamine; Proliferation

Indexed keywords

ORNITHINE DECARBOXYLASE;

ARTICLE; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENE TARGETING; GENE THERAPY; GENETICS; HUMAN; METABOLISM; METHODOLOGY; NEOPLASM; TUMOR CELL LINE;

CELL LINE, TUMOR; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE TARGETING; GENE THERAPY; HUMANS; NEOPLASMS; ORNITHINE DECARBOXYLASE;

ADENOVIRIDAE;

EID: 41049086348     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1111/j.1745-7270.2008.00397.x     Document Type: Article

References (34)

1. Radice D, Redaelli A. Breast cancer management: quality-of-life and cost considerations. Pharmacoeconomics 2003, 21 : 383 396.
2. Tabor CW, Tabor H. Polyamines. Ann Rev Biochem 1984, 53 : 749 790.
3. Sunkara PS, Rosenberger AL. Antimetastatic activity of DL-alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, in mice. Cancer Res 1987, 47 : 933 935.
4. Thomas T, Thomas TJ. Polyamine metabolism and cancer. J Cell Mol Med 2003, 7 : 113 126.
5. Young L, Salomon R, Au W, Allan C, Russel P, Dong Qi. Ornithine decarboxylase (ODC) expression pattern in human prostate tissues and ODC transgenic mice. J Histochem Cytochem 2006, 54 : 223 229.
6. Pegg AE. Polyamine metabolism and its importance in neoplastic growth and a target for chemotherapy. Cancer Res 1988, 48 : 759 774.
7. Tabib A, Bachrach U. Role of polyamines in mediating malignant transformation and oncogene expression. Int J Biochem Cell Biol 1999, 31 : 1289 1295.
8. Auvinen M, Paasinen A, Andersson LC, Hölttä E. Ornithine decarboxylase activity is critical for cell transformation. Nature 1992, 360 : 355 358.
9. Moshier JS, Dosescu J, Skunca M, Luk GD. Transformation of NIH/3T3 cells by ornithine decarboxylase overexpression. Cancer Res 1993, 53 : 2618 2622.
10. Canizares F, Salinas J, De las heras M, Diaz J, Tovar I, Martinez P, Penafiel R. Prognostic value of ornithine decarboxylase and polyamines in human breast cancer: correlation with clinicopathologic parameters. Cancer Res 1999, 5 : 2035 2041.
11. Manni A, Astrow SH, Gammon S, Thompson J, Mauger D, Washington S. Immunohistochemical detection of ornithine-decarboxylase in primary and metastatic human breast cancer specimens. Breast Cancer Res Treat 2001, 67 : 147 156.
12. Zhang Y, Liu XX, Zhang B, Hu HY, Gong L. Antitumor effect of antisense ODC adenovirus on human prostate cancer cells. Prostate Cancer Prostatic Dis 2005, 8 : 280 286.
13. Zhang B, Liu XX, Zhang Y, Jiang CY, Hu HY, Gong L, Liu M et al. Adenovirus-mediated expression of both antisense ODC and AdoMetDC inhibited colorectal cancer cell growth in vitro. Acta Phamacol Sin 2006, 27 : 353 359.
14. Tian H, Li L, Liu XX, Zhang Y. Antitumor effect of antisense ornithine decarboxylase adenovirus on human lung cancer cells. Acta Biochim Biophys Sin 2006, 38 : 410 416.
15. Zhang Y, Liu X, Hu H, Geng Z, Wang X, Zhang B. Construction of an antisense RNA recombinant adenovirus vector of the third extron in ODC gene. Journal of Shandong University (Health Sciences) 2003, 41 : 371 374.
16. Prevec L, Christie BS, Laurie KE, Bailey MM, Graham FL, Rosenthal KL. Immune response to HIV-1 gag antigens induced by recombinant adenovirus vectors in mice and rhesus macaque monkeys. J Acquir Immune Defic Syndr 1991, 4 : 568 576.
17. Wei D, Tang Z, Chen S. Construction of recombinant adenovirus vector containing mIL-12 using the method of homogenous re combination in bacteria and its expression in vitro with high efficiency. Chin J Biochem Mol Biol 2000, 16 : 716 721.
18. Auvinen M, Laine A, Paasinen-Sohns A, Kangas A, Kangas L, Saksela O, Andersson LC et al. Human ornithine decarboxylase-overpro-ducing NIH3T3 cells induce rapidly growing, highly vascularized tumors in nude mice. Cancer Res 1997, 57 : 3016 3025.
19. Wallace HM, Duthie J, Evans DM, Lamond S, Nicoll KM, Heys SD. Alterations in polyamine catabolic enzymes in human breast cancer tissue. Clin Cancer Res 2000, 6 : 3657 3661.
20. Leveque J, Foucher F, Bansard JY, Havouis R, Grall JY, Moulinoux JP. Polyamine profiles in tumor, normal tissue of the homologous breast, blood, and urine of breast cancer sufferers. Breast Cancer Res Treat 2000, 60 : 99 105.
21. Seiler N, Raul F. Polyamines and apoptosis. J Cell Mol Med 2005, 9 : 623 642.
22. Moshier JA, Skunca M, Wu W, Boppana SM, Rauscher FJ 3rd., Dosescu J. Regulation of ornithine decarboxylase gene expression by the Wilms' tumor suppressor WT1. Nucleic Acids Res 1996, 24 : 1149 1157.
23. 11-diethylnorspermine retards S phase progression within one cell cycle. Eur J Biochem 2000, 267 : 4157 4164.
24. Love RR, Astrow SH, Cheeks AM, Havighurst TC. Ornithine decarboxylase (ODC) as a prognostic factor in operable breast cancer. Breast Cancer Res Treat 2003, 79 : 329 334.
25. Pegg AE. Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy. Cancer Res 1988, 48 : 759 774.
26. Metcalf B, Bey P, Danzin C, Jung M, Casara P, Vevert J. Catalytic irreversible inhibition of mammalian ornithine decarboxylase (EC 4.1.1.17) by substrate and product analogues. J Amer Chem Soc 1978, 100 : 2551 2553.
27. Clerico L, Mancuso T, Da Prato L, Marziliano N, Garagna S, Pecile V, Demori E et al. In situ RT-PCR allows the detection of ornithine decarboxylase mRNA in paraffin embedded archival human hyperplastic breast tissues. Eur J Histochem 1999, 43 : 179 183.
28. Bettuzzi S, Davalli P, Astancolle S, Pinna C, Roncaglia R, Boraldi F, Tiozzo R et al. Coordinate changes of polyamine metabolism regulatory proteins during the cell cycle of normal human dermal fibroblasts. FEBS Lett 1999, 446 : 18 22.
29. Sherr CJ. Cancer cell cycles. Science 1996, 274 : 1672 1677.
30. Buckley MF, Sweeney KJ, Hamilton JA, Sini RL, Manning DL, Nicholson RI, deFazio A et al. Expression and amplification of cyclin genes in human breast cancer. Oncogene 1993, 8 : 2127 2133.
31. Sweeney KJ, Musgrove EA, Watts CK, Sutherl RL. Cyclins and breast cancer. Cancer Treat Res 1996, 83 : 141 170.
32. Weinstat SD, Merino MJ, Manrow RE, Lawrence JA, Bluth RF, Wittenbel KD, Simpson JF et al. Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions. Nat Med 1995, 1 : 1257 1260.
33. Thomas TJ, Shah N, Faaland CA, Gallo MA, Yurkow E, Satyaswaroop PG, Thomas T. Effects of a bis(benzyl)spermine analog on MCF-7 breast cancer cells in culture and nude mice xenografts. Oncol Rep 1997, 4 : 15 21.
34. Thomas T, Trend B, Butterfield JR, Janne OA, Kiang DT. Regulation of ornithine decarboxylase gene expression in MCF-7 breast cancer cells by antiestrogens. Cancer Res 1989, 49 : 5852 5857.